Abivax SA (ABVX)
123.02
-0.96
(-0.78%)
USD |
NASDAQ |
Mar 19, 16:00
126.00
+2.98
(+2.42%)
After-Hours: 05:09
Abivax Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 855.92B |
| AstraZeneca PLC | 316.83B |
| DBV Technologies SA | 1.015B |
| Inventiva SA | 829.60M |
| Cellectis SA | 277.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -179.22M |
| Total Expenses (Quarterly) | 179.22M |
| EPS Diluted (Quarterly) | -2.457 |